Home / Industry Reports / Therapeutic Area Market Research
Sort By: Title Date Price

Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth

GBI Research, the leading business intelligence provider, has released its latest research: ‘Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth’, which provides insights into psoriasis therapeutics in the Asia-Pacific (APAC) market. For the purposes of this report, APAC refers to the market in China, India, Japan, and Australia only. The report estimates the market size for 2014, along with forecasts until 2021. It also covers disease epidemiology, treatment algorithms, treatment use patterns, in-depth analysis of pipeline molecules, clinical trial failure rates, and analysis of recent deals. It is built using data and information sourced from proprietary databases, primary and secondary

$4995 Read More

Global Radiation Therapy Market Report: 2015 Edition

Radiotherapy is a treatment procedure that involves the use of high-energy radiation. It is commonly applied to the cancerous tumor because of its ability to control cell growth and is also used to treat benign (non-cancerous) tumors and other conditions like thyroid disease and some blood disorders. Almost half of the cancer patients are being treated by radiation therapy. Nowadays, new treatment techniques such as image guided radiation therapy (IGRT), proton therapy; brachytherapy and stereotactic radiation therapy are being increasingly adopted. Moreover, due to the less risk in proton therapy treatment, it has become the most preferred option for treating cancer.

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

Competitor Analysis: Therapeutic Antibodies 2015: Biosimilars & Biosuperiors This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of April 2015. Total sales of recombinant therapeutic monoclonal antibodies originating from companies located in regulated markets reached US$ 82.2 bln (+8.6% vs previous year) in the year 2014.

$1500 Read More

Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

This report provides an update of recombinant coagulation factors used for controlling bleeding of hemophilia A and B and other bleeding disorders. 2013 sales figures and 2014 nine-month sales data are analyzed to evaluate commercial development of the market under the light of a strong pipeline and entry of new competitor products into the market. The profiles of drug candidates in development are presented in details not only for recombinant coagulation factors VIII, IX and VII, but also for emerging alternative procoagulants, gene therapeutics and immune tolerance inducing agents.

$2795 Read More

Peptide Therapeutics Pipeline Database: 1-Year Subscription

Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files. Each project (file) is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic peptides is intuitive. Data sets of interest can be printed and exported in Word or Excel format. Projects are being updated continuously by passive and active searches. Information from press releases is entered on a daily basis.

$1016 Read More

Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders

This business report from July 2014 is based on the identification, description and assessment of all relevant stakeholders in the field of botulinum neurotoxins. The report analyzes the existing product portfolios in regulated and less regulated markets, commercial information, and measures to maintain sales and market shares by upside indications and life cycle management measures. The report addresses the new wave of botulinum neurotoxin product candidates in development, such as biosimilars and biosuperior botulinum neurotoxins.

$2656 Read More

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014

Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of March 2014. Marketed antibodies are attractive for companies to create next generation variants and  biosimilar copies because they represent clinically and commercially validated products.

$1523 Read More

Gastrointestinal Deals and Alliances of 2014

The Gastrointestinal Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

$1495 Read More

Central Nervous System Deals and Alliances of 2014

The Central Nervous System Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

$1495 Read More

Motor Neurone Disease Partnering 2010-2015

The report provides an analysis of motor neurone partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors motor neurone technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Motor Neurone Disease Partnering 2015

The report provides an analysis of motor neurone partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors motor neurone technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)

GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis)” by Kelly Scientific Publications is a comprehensive report on the cancer biomarker industry and its impact on the health system.

$3400 Read More

The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019)

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry.

US - Pain Management Therapeutics Patients & Market Analysis

Pain management is one of the fast growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The United States pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain.

$1100 Read More

US and Japan - Proton Therapy Market, Patients & Forecast

Proton therapy has become a subject of considerable interest in the radiation oncology community and it is expected that there will be a substantial growth in proton treatment facilities during the next decade. Proton therapy, one of the most intriguing developments in cancer treatment, carries a price tag as intimidating as its size. At a cost of US$ 125 Million, and sometimes much more, today’s centers usually fill a city block.

$1475 Read More

Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line

Non-Small Cell Lung Cancer (NSCLC) is the second most common cancer globally, and the most common cause of cancer-related mortality. Such a poor outlook, particularly for patients with advanced disease, has created a pressing need for improved therapeutic options.

$4995 Read More

Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth

Hepatitis B is an infectious liver disease caused by the Hepatitis B Virus (HBV) and characterized by acute or chronic inflammation of the liver. Despite its status as a vaccine-preventable disease, it remains a serious global health concern. Incidence tends to be higher in countries with a significant number of migrants from medium and high-prevalence countries. 

$4995 Read More

North America Cardiac Resynchronization Therapy Devices Industry 2015 Market Research Report

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cardiac Resynchronization Therapy Devices market analysis is provided for the North America markets including development trends, competitive landscape analysis, and key regions development status.

$3800 Read More

Therapeutic Area Market Research Reports

A therapeutic area usually refers to a specific category of disease that has known medical treatments, drugs or other potential drug innovations. It is a process of categorizing medical drugs without referring to any kind of treatment or without taking a glance at the ailment that it treats. For example, cardiology can be considered in the therapeutic area. Likewise, other sections like urology, travel medicine, psychotherapy, dermatology and gynecological therapy can be bifurcated as therapeutic area also.

The worldwide treatment sector encompasses therapies that are designed to cure or handle particular ailments or diseases inside he internal system of the body. Nonetheless, the therapeutic area therapy and its consequent situations fluctuate in parallel and widely.

Representing digital/online leading market research reports from market experts , industry professionals and market analysts, Acute Market Reports is your unique /exceptional, investigative and comprehensive knowledge source for therapeutic area. The reason being that we source our market research reports from well established, branded and reputed publishers of the industry.

Our market reports fulfill your business requirements and fits your budget. It encompasses detailed information and analysis of market, market segments, market size, market edifice, market sections, business overview, company profile, market overview, competitive landscape, competive strategy, business strategy, product portfolio, benchmarking trends, technological trends, market growth factors, industry inhibitors, market share analysis, value chain analysis, micro environment of market, macro market environment , market attractiveness analysis, SWOT analysis, Strategic analysis, business process reengineering and environmental scanning represented through pictorial representation like graphs, diagrams, charts, excel sheets or spreadsheets and tables.